|
Market Closed -
Australian S.E.
01:12:36 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 3.530 AUD | -3.02% |
|
+4.13% | +56.19% |
| 10-11 | Cogstate Contracted Fiscal 2027 Revenue Rises to $56.8 Million After September Quarter Sales | MT |
| 09-25 | Morgans Financial Starts Cogstate at Buy with AU$4.07 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 436M | |||||
| 68.92B | |||||
| 51.9B | |||||
| 48.73B | |||||
| 43.13B | |||||
| 41.48B | - | - | - | - | - |
- Stock Market
- Stocks
- CGS Stock
- Charts Cogstate Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
